- Filed
- May 22, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · May 20, 2025 | 299.67M sh |
| Short Term Investments | FY 2025 · Mar 31, 2025 | $96.19M |
| Short Term Investments | FY 2025 · Mar 31, 2024 | $57.89M |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $778.98M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $1.26B |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $1.39B |
| Current Assets | FY 2025 · Mar 31, 2024 | $1.61B |
| Total Assets | FY 2025 · Mar 31, 2024 | $3.41B |
| Shares Diluted | FY 2025 · Mar 31, 2023 | 291.62M sh |
| Stock Repurchased | FY 2025 · Mar 31, 2023 | $0 |
| Capex | FY 2025 · Mar 31, 2023 | $21.54M |
| Operating Cash Flow | FY 2025 · Mar 31, 2023 | $354.89M |
| Eps Diluted | FY 2025 · Mar 31, 2023 | $0.37 |
| Eps Basic | FY 2025 · Mar 31, 2023 | $0.38 |
| Sga Expense restated | FY 2025 · Mar 31, 2023 | $150.17M |
| Rd Expense | FY 2025 · Mar 31, 2023 | $218.35M |
| Net Income | FY 2025 · Mar 31, 2023 | $107.96M |
| Operating Income | FY 2025 · Mar 31, 2023 | $92.81M |
| Gross Profit | FY 2025 · Mar 31, 2023 | $935.64M |
| Cost Of Revenue | FY 2025 · Mar 31, 2023 | $222.89M |
| Revenue | FY 2025 · Mar 31, 2023 | $1.16B |
| Stockholders Equity | FY 2025 · Mar 31, 2022 | $1.3B |